Northern Trust and Saphyre Enhance Onboarding for Investment Operations Outsourcing Clients
Cloud-based application leverages Saphyre’s AI platform to automate information collection and sharing to support investment…
Cloud-based application leverages Saphyre’s AI platform to automate information collection and sharing to support investment…
PITTSBURGH–(BUSINESS WIRE)–$SMSI #40thanniversary–Smith Micro Software, Inc. (the “Company” or Smith Micro”) (NASDAQ: SMSI) is commemorating…
UK, Reading. November 29, 2022 – IGEL, provider of the managed endpoint operating system for…
New program harnesses the world’s top ethical hackers to enhance product security NEW YORK, Nov….
NESS ZIONA, Israel, Nov. 29, 2022 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX”…
NESS ZIONA, Israel, Nov. 29, 2022 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX”…
Recent achievements showcase company’s leadership as CRO Partner and Employer of Choice in the Asia/Pacific region…
Recent achievements showcase company’s leadership as CRO Partner and Employer of Choice in the Asia/Pacific region…
TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
Avero Diagnostics to Develop and Commercialize, Enabling Potential Future Revenue for Biora Therapeutics SAN DIEGO,…
Avero Diagnostics to Develop and Commercialize, Enabling Potential Future Revenue for Biora Therapeutics SAN DIEGO,…
Investigators to present efficacy and safety data of ARX788 treatment in patients with HER2+ metastatic…
Investigators to present efficacy and safety data of ARX788 treatment in patients with HER2+ metastatic…
ESTERO, Fla., Nov. 29, 2022 (GLOBE NEWSWIRE) — Mushrooms Inc. (OTC: MSRM) (the “Company”), formerly…
ESTERO, Fla., Nov. 29, 2022 (GLOBE NEWSWIRE) — Mushrooms Inc. (OTC: MSRM) (the “Company”), formerly…
New York, NY, and Tel Aviv, ISRAEL, Nov. 29, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical,…
New York, NY, and Tel Aviv, ISRAEL, Nov. 29, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical,…
New clinical data to be presented from the Company’s phase 2 clinical trial of CAN-2409…
New clinical data to be presented from the Company’s phase 2 clinical trial of CAN-2409…